Add this topic to your myFT Digest for news straight to your inbox
Some companies would prefer if people stayed indoors more
Swiss pharmaceuticals group raises offer for US diagnostics company
Boutique banks are closing the gap on their bulge-bracket rivals in a difficult market – and squeezing those in the middle
As many of the world’s elite gathered in Davos, corporate titans stole some of their limelight
Roche has seen off poison pill defences before without the price rising too much
FOMC meetings leads to afternoon rally
The offer is 43 per cent above Illumina’s three-month average share price
International Edition